ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors
about
sameAs
The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) familyThe periovulatory period in cattle: progesterone, prostaglandins, oxytocin and ADAMTS proteasesAggrecanases and cartilage matrix degradationTissue inhibitors of metalloproteinasesExpression and regulation of metalloproteinases and their inhibitors in intervertebral disc aging and degenerationThe metalloproteinase ADAMTS1: a comprehensive review of its role in tumorigenic and metastatic pathways.ADAMTS8 and ADAMTS15 expression predicts survival in human breast carcinomaEndothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndromeDiscovery and characterization of a novel, widely expressed metalloprotease, ADAMTS10, and its proteolytic activationEndocardial Brg1 represses ADAMTS1 to maintain the microenvironment for myocardial morphogenesisADAMTS7B, the full-length product of the ADAMTS7 gene, is a chondroitin sulfate proteoglycan containing a mucin domainFibulin-1 acts as a cofactor for the matrix metalloprotease ADAMTS-1Adamts-1 is essential for the development and function of the urogenital systemIdentification and characterization of ADAMTS-20 defines a novel subfamily of metalloproteinases-disintegrins with multiple thrombospondin-1 repeats and a unique GON domainBiosynthesis and expression of a disintegrin-like and metalloproteinase domain with thrombospondin-1 repeats-15: a novel versican-cleaving proteoglycanaseThe ADAMTS metalloproteinasesAge-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin.ADAMTS1 interacts with, cleaves, and modifies the extracellular location of the matrix inhibitor tissue factor pathway inhibitor-2.Progress in matrix metalloproteinase research.PGF2α-F-prostanoid receptor signalling via ADAMTS1 modulates epithelial cell invasion and endothelial cell function in endometrial cancer.ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'.ADAM and ADAMTS family proteins and their role in the colorectal cancer etiopathogenesis.Relevance of IGFBP2 proteolysis in glioma and contribution of the extracellular protease ADAMTS1Variable inhibition of thrombospondin 1 against liver and lung metastases through differential activation of metalloproteinase ADAMTS1.ADAMTS-4 and ADAMTS-5: key enzymes in osteoarthritis.Determinants of versican-V1 proteoglycan processing by the metalloproteinase ADAMTS5ADAMTS4 (aggrecanase-1) activation on the cell surface involves C-terminal cleavage by glycosylphosphatidyl inositol-anchored membrane type 4-matrix metalloproteinase and binding of the activated proteinase to chondroitin sulfate and heparan sulfateReactive-site mutants of N-TIMP-3 that selectively inhibit ADAMTS-4 and ADAMTS-5: biological and structural implicationsRegulation of thrombospondin1 by extracellular proteases.Transcriptome-wide analysis of messenger RNA decay in normal and osteoarthritic human articular chondrocytesMetalloproteinases: their role in arthritis and potential as therapeutic targets.ADAMTS1 mediates the release of antiangiogenic polypeptides from TSP1 and 2Expression profiling of metalloproteinases and their inhibitors in synovium and cartilage.The ADAMTS1 protease gene is required for mammary tumor growth and metastasis.Endothelial cells express a unique transcriptional profile under very high wall shear stress known to induce expansive arterial remodelingPericyte TIMP3 and ADAMTS1 modulate vascular stability after kidney injury.Matrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Adamts1 mediates ethanol-induced alterations in collagen and elastin via a FoxO1-sestrin3-AMPK signaling cascade in myocytes.ADAMTS13 and 15 are not regulated by the full length and N-terminal domain forms of TIMP-1, -2, -3 and -4.Matrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.
P2860
Q21146633-1E7CF5F1-1EDE-4544-B470-47067B9524B0Q24597933-AAE33B4B-AD0E-4B24-B2C9-9EB4D74F32D3Q24804310-9DBDC1C7-7193-4704-9D2C-7588A2F7EA89Q26829539-5D95FF2E-DCEE-4AAA-9264-C335162BE02FQ27009408-C782DD56-C3EF-47BA-BD4B-DF2196C713A1Q27687896-F24D4A6D-8AFA-465E-868D-C7F694686592Q28271466-E1F029E3-96D8-41F4-A8B2-00CCF6CD1A2DQ28277874-04A5B219-08EC-49C6-885F-5F48DE5FB0A3Q28280996-4685C2EF-4A47-422E-83B3-F9FB330F9497Q28511878-3EBC3CAA-A39B-4444-B6DC-A217416B3F9EQ28512997-DD3961A0-9F58-40FC-B296-5DE5A2C2E4F1Q28586832-87E63AD4-1352-4CFD-B056-90EA7312636FQ28588557-84BA2604-E986-4DC7-AD0C-CD037A478260Q28591587-B8756AC8-0F13-4FF1-8D70-F8F3E763E6E8Q28594757-B77B1CC0-8053-44D3-B2AA-46081E7AE211Q29544428-91466272-D1D4-4214-AC61-3545100094B2Q31134336-9EFC2258-0088-4D35-87E9-6D84B2294DF0Q33241217-61A979BE-11D0-4B1A-AA26-2BFE8A6FC041Q33608536-4C34C421-5F14-45A7-9387-57A2BCBD4945Q33692377-5DD353EF-4516-4EBE-A460-58323AF7AF00Q33808240-395E52AA-5D8D-4514-BDFB-2F94EA446599Q34049378-B79D9127-D739-41CD-9072-6C5D95B58D2AQ34100940-9D4364A4-66BE-46D7-99B0-73CB6AAD7478Q34108282-40DF696C-4040-4D00-9818-E0920FB01C23Q34205901-389C82C8-9B56-4C07-8C19-D4C037BC3E53Q34283551-F1E47BF7-A483-4CAF-AB2D-B51A8F8A58BEQ34287261-EE58FDC8-EBE2-4F72-A798-5987058AEAC5Q34412131-0C724F4D-C55E-41FB-B13E-0E839A360AB2Q34441372-4CD8E6C7-E51F-4245-86B0-7E4B0E46785CQ34521922-4C8E706F-CD00-4F9D-B560-6371ECA7CEF5Q35056019-23F20C82-E40C-446C-B92F-AF4E577C45C1Q35130971-F11ADD61-0A71-423A-ABE4-467A16446516Q35605620-864CAD27-5E44-4AD5-8243-F281B40380CDQ35679442-ADD7D390-9C85-4CFC-8D80-E02609F2466DQ35900684-3E73E8A4-D30E-4F98-9E9E-5D08A8F51C1AQ35917508-AF3BCB7E-FBE8-4B92-BD82-85A99D827CEEQ36009930-A24C4444-1F31-41EA-9643-E51DD0969121Q36478984-38179DE1-0C44-4754-AFBF-F3E4C00CD27AQ36502133-2BCBCED1-959E-464B-A517-77CB67F8570DQ36644577-43891D0D-E928-4332-872D-C18CE4E52DEA
P2860
ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors
description
2002 nî lūn-bûn
@nan
2002 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@ast
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@en
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@nl
type
label
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@ast
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@en
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@nl
prefLabel
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@ast
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@en
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@nl
P2093
P3181
P1476
ADAMTS1 cleaves aggrecan at mu ...... y metalloproteinase inhibitors
@en
P2093
Alfonso Luque
Gillian Murphy
Jennifer Westling
John D Sandy
Juan Carlos Rodríguez-Manzaneque
M Luisa Iruela-Arispe
Shelley N-M Thai
P304
P3181
P356
10.1016/S0006-291X(02)00254-1
P407
P50
P577
2002-04-01T00:00:00Z